Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 14, 2009 13:51 ET | Source: Mauna Kea Technologies

Institut Pasteur Researchers Demonstrate Microscopic, Deep Brain Imaging in Freely Moving Mice, Detecting GFP Molecule

PARIS, Jan. 14, 2009 (GLOBE NEWSWIRE) -- Institut Pasteur researchers have demonstrated microscopic, real-time imaging of the deepest regions of the brain in a freely moving mouse, using it to analyze...
January 13, 2009 09:00 ET | Source: Cavallino LLC

Cavallino LLC Launches 2009 Consumer Shopping Intentions Study At the National Retail Federation 96th Annual Convention and Expo

NEW YORK, Jan. 13, 2009 (GLOBE NEWSWIRE) -- Cavallino LLC, the private equity and consulting firm, released the 2009 Consumer Shopping Intentions Study to a receptive audience at "The Big Show,"...
January 13, 2009 09:00 ET | Source: G. Palmer & Associates

Labor Forecast Predicts 21.2 Percent Decrease in Demand for Temporary Workers in 2009 First Quarter, Representing Eighth Consecutive Quarter of Declines

NEWPORT BEACH, Calif., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Demand for temporary workers in the United States for the 2009 first quarter is expected to fall 21.2% on a seasonally adjusted basis over the...
January 13, 2009 08:00 ET | Source: BSD Medical Corporation

BSD Medical Corporation: Hyperthermia Therapy Contributes to 85 Percent Survival Rate From Childhood Cancers

SALT LAKE CITY, Jan. 13, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reviewed the encouraging survival rate from clinical research on children and adolescents with cancer as...
January 13, 2009 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Begins Phase 2 Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer

BERKELEY HEIGHTS, N.J., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that the company has begun treating patients in a Phase 2, open...
January 12, 2009 09:30 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Studies

WORCESTER, Mass., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today the publication of a report reviewing the studies performed to...
January 12, 2009 09:00 ET | Source: Timberline Resources Corporation

Timberline Receives Positive Hydrogeologic Test Results At Its Butte Highlands Gold Project

COEUR D'ALENE, Idaho, Jan. 12, 2009 (GLOBE NEWSWIRE) -- Timberline Resources Corporation (NYSE Alternext:TLR) today announced the completion of a hydrogeologic study at its 100-percent owned,...
January 09, 2009 09:00 ET | Source: C. K. Cooper & Company

C. K. Cooper & Company Initiates Coverage of Brigham Exploration Co.

IRVINE, Calif., Jan. 9, 2009 (GLOBE NEWSWIRE) -- C. K. Cooper & Company, an independent, full-service investment bank, headquartered in Irvine, California, announced today that it has initiated...
January 08, 2009 11:05 ET | Source: Cellvizio Inc.

Cellvizio Announces That University of Colorado Physicians Treat First U.S. Patients in Large Study to Confirm If Live, Microscopic Imaging Enhances a Physician's Ability to Differentiate Cancerous Lesions in the Bile and Pancreatic Ducts

FORT WASHINGTON, Pa., Jan. 8, 2009 (GLOBE NEWSWIRE) -- Doctors at the University of Colorado Hospital in Aurora have treated the first patients in a study to confirm whether using Cellvizio(r), the...
January 08, 2009 08:00 ET | Source: PricewaterhouseCoopers

PricewaterhouseCoopers Urges Financial Organizations to Increase Vigilance and Oversight of Information Privacy and Data Security

NEW YORK, Jan. 8, 2009 (GLOBE NEWSWIRE) -- Financial services firms, traditionally considered leaders in privacy and information security, are discovering that the process of protecting sensitive...